Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimou

Showing results (501-510 of 610) with videos related to

Pageof 61
Sort By:
Cancer Medicine|December 29, 2023
Leisure time television watching, computer use and risks of breast, colorectal and prostate cancer: A Mendelian randomisation analysisNikos Papadimitriou, Nabila Kazmi, Niki Dimou, et al.
Molecular Neurodegeneration|April 18, 2023
NF-κB is a critical mediator of post-mitotic senescence in oligodendrocytes and subsequent white matter lossJudith Stefanie Schlett, Melanie Mettang, Aladdin Skaf, et al.
International Journal of Cancer|October 10, 2020
Circulating adipokine concentrations and risk of five obesity-related cancers: A Mendelian randomization studyNiki L Dimou, Nikos Papadimitriou, Daniela Mariosa, et al.
Hematological Oncology|October 31, 2022
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab eraTheodoros P Vassilakopoulos, Fotios Panitsas, Zois Mellios, et al.
Therapeutic Advances in Hematology|December 21, 2020
Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromesSotirios G Papageorgiou, Ioannis Kotsianidis, Anthi Bouchla, et al.
British Journal of Haematology|August 31, 2020
The effect of 5-azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomesPanagiotis T Diamantopoulos, Argiris Symeonidis, Vasiliki Pappa, et al.
Frontiers in Medicine|October 30, 2023
Caplacizumab for immune thrombotic thrombocytopenic purpura: real-world multicenter dataEleni Gavriilaki, Emmanuel Nikolousis, Eudoxia-Evaggelia Koravou, et al.
Hematological Oncology|May 22, 2012
Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without RituximabSotirios G Papageorgiou, Panayiotis Diamantopoulos, Georgia Levidou, et al.
BMJ (Clinical Research Ed.)|November 2, 2017
Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation studyVasiliki I Dimitrakopoulou, Konstantinos K Tsilidis, Philip C Haycock, et al.
Scientific Reports|April 18, 2025
Mendelian randomization study of sleep traits and risk of colorectal cancerOlympia Dimopoulou, Harriett Fuller, Rebecca C Richmond, et al.
Pageof 61

Showing results (501-510 of 610) with videos related to

Sort By:
Pageof 61
Cancer Medicine|December 29, 2023
Leisure time television watching, computer use and risks of breast, colorectal and prostate cancer: A Mendelian randomisation analysisNikos Papadimitriou, Nabila Kazmi, Niki Dimou, et al.
Molecular Neurodegeneration|April 18, 2023
NF-κB is a critical mediator of post-mitotic senescence in oligodendrocytes and subsequent white matter lossJudith Stefanie Schlett, Melanie Mettang, Aladdin Skaf, et al.
International Journal of Cancer|October 10, 2020
Circulating adipokine concentrations and risk of five obesity-related cancers: A Mendelian randomization studyNiki L Dimou, Nikos Papadimitriou, Daniela Mariosa, et al.
Hematological Oncology|October 31, 2022
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab eraTheodoros P Vassilakopoulos, Fotios Panitsas, Zois Mellios, et al.
Therapeutic Advances in Hematology|December 21, 2020
Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromesSotirios G Papageorgiou, Ioannis Kotsianidis, Anthi Bouchla, et al.
British Journal of Haematology|August 31, 2020
The effect of 5-azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomesPanagiotis T Diamantopoulos, Argiris Symeonidis, Vasiliki Pappa, et al.
Frontiers in Medicine|October 30, 2023
Caplacizumab for immune thrombotic thrombocytopenic purpura: real-world multicenter dataEleni Gavriilaki, Emmanuel Nikolousis, Eudoxia-Evaggelia Koravou, et al.
Hematological Oncology|May 22, 2012
Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without RituximabSotirios G Papageorgiou, Panayiotis Diamantopoulos, Georgia Levidou, et al.
BMJ (Clinical Research Ed.)|November 2, 2017
Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation studyVasiliki I Dimitrakopoulou, Konstantinos K Tsilidis, Philip C Haycock, et al.
Scientific Reports|April 18, 2025
Mendelian randomization study of sleep traits and risk of colorectal cancerOlympia Dimopoulou, Harriett Fuller, Rebecca C Richmond, et al.
Pageof 61